OBJECTIVES: Infective endocarditis (IE) remains a life-threatening disease, despite the improvement in diagnostic and therapeutic measures. We reviewed our outcomes for all adults who underwent surgery for endocarditis at our centre.
INTRODUCTION
Infective endocarditis (IE) remains a serious disease that is associated with significant morbidity and mortality. The overall incidence is relatively low, about 5/100 000 person-years [1] . In the current era, aggressive medical therapy and earlier surgical interventions with few exceptional circumstances have been the goal. Recent literature shows relatively stable mortality rates, despite the improvement in diagnostic and therapeutic tools including medical therapy and surgical techniques [2] . In this report, we reviewed our long-term outcome of surgery for IE both native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE).
PATIENTS AND METHODS
Mayo Clinic institutional review board approved the collection and data analysis for this study. This is a retrospective review of a prospectively collected database to identify all the patients who underwent surgery for IE. Diagnosis was based on modified Duke's criteria and was confirmed intraoperatively by pathological and laboratory analyses.
Between January 1995 and December 2013, 801 patients underwent surgery for IE. The general principles of surgery for endocarditis were followed, which include radical removal of all infected materials and proper debridement with subsequent reconstruction.
Patients' records were reviewed and data regarding patient characteristics, operative findings and techniques, perioperative morbidity and mortality and follow-up outcomes were collected.
Statistical analysis
We used multiple logistic regression, Kaplan-Meier survival analyses and Cox proportional hazard models to identify the risk factors associated with early mortality and late mortality.
RESULTS
We identified 801 patients with an IE who underwent surgery at our institution during the study period. Baseline characteristics are presented in Table 1 . The majority of our patients were men (586 patients, 73%), with a mean age of 60 ± 14.7 years. Emergent/urgent surgery for active endocarditis was performed in 379 (47%) patients. Preoperative dialysis was required in 62 (8%) patients. A total of 149 patients suffered stroke prior to their surgery. We have divided the time interval between the neurological event and the surgery date into recent (if it was 2 weeks or less) or remote (if it was more than 2 weeks interval). Twentynine (19%) patients had their surgery in less than 2 weeks period from the onset of stroke.
PVE occurred in 429 (54%) patients, and aortic root abscess was the main indication for surgery in 114 (14%) patients. Isolated aortic valve (AV) endocarditis was present in the majority of patients (392 patients, 49%), whereas mitral valve (MV) endocarditis was present in 159 (20%) patients, and 250 (31%) patients had multivalve including tricuspid valve infection.
The most common valve procedure was isolated AV replacement (392 patients, 49%). The most common prostheses used were mechanical prostheses (312 patients, 39%), while bioprostheses and homografts were used in 283 (35%) patients and 84 (11%) patients, respectively. Valve repair was possible in 122 (15%) patients.
Postoperative dialysis was required in 59 (7%) patients and 16 (2%) patients suffered postoperative stroke. The mean followup period was 5 ± 4.8 years (maximum 20 years).
Overall 30-day mortality was 8%. Predictors of early mortality are presented in Table 2 . Multivariate analysis shows active endocarditis (P = 0.001), preoperative dialysis (P = 0.011), previous coronary artery bypass surgery (P < 0.001), the presence of aortic root abscess (P = 0.024), multivalve involvement (P = 0.001) and postoperative renal failure requiring dialysis (P = 0.001) to be significant predictors of early mortality. Preoperative stroke was not associated with perioperative mortality (P = 0.751).
Overall survival at 5, 10 and 20 years was 68%, 45% and 8%, respectively. Figure 1 shows the long-term survival based on the type of valve involved. Isolated AV endocarditis had better survival in comparison with isolated MV or multivalve involvement. The 5-, 10-and 20-year survival for isolated AV endocarditis was 75%, 50% and 20%, respectively (P < 0.001). The 5-, 10-, and 20-year survival for isolated MV endocarditis and for multivalve involvement were 65%, 40% and 10% and 55%, 35% and 5%, respectively.
Predictors of late mortality are presented in Table 3 . Multivariate analysis identified the following as significant: need for dialysis [adjusted hazard ratio (aHR) = 2.6, P < 0.001], previous coronary artery bypass surgery (aHR = 2, P < 0.001), MV endocarditis (aHR = 2.4, P = 0.006), multivalve involvement including the tricuspid valve (aHR = 2.2, P = 0.007) and postoperative renal failure requiring dialysis (aHR = 3.8, P < 0.001). Mechanical valves were associated with the best long-term survival when compared to bioprostheses, homografts or valve repair (P = 0.001). In Fig. 2 , the 5-, 10-and 20-year survival for mechanical prostheses was 75%, 55% and 20%, respectively. For those who required bioprostheses, the 5-, 10-, and 20-year survival was 62%, 30% and 10%, respectively, and for homografts, 5-, 10-, and 15-year-survival was 60%, 45% and 45%, respectively. Predictors of reoperation are presented in Table 4 . Figure 3 shows the survival based on the number of valve involvement with multivalve involvement carrying the worst outcomes (P < 0.001). Long-term survival was not different between NVE and PVE (P = 0.904). Overall, patients who had active endocarditis at the time of surgery had the worst outcomes with 5-and 10-year survival of 60% and 40%, respectively, compared with those who had healed endocarditis 75% and 50%, respectively (P = 0.01) (Fig. 4) .
DISCUSSION
This study represents our experience with surgical treatment of IE. Till now, these cases still represent several challenges in the diagnosis and management and overall carry unfavourable early and late outcomes. The indications for surgery may seem to be clear in the majority of circumstances; however, there are several other clinical scenarios that represent major dilemmas to the surgeon.
The median age in our population was 60 years, which is in line with the majority of epidemiological studies on IE [3] . In the international collaboration on endocarditis study (ICE-PCS), the median age was 57.9 years [4] . There is an observed overall rise in the incidence of endocarditis recently specially after the change of the guidelines for antibiotic prophylaxis in 2007 [5] .
The overall mortality in our series was 8%, which is a survival rate that is close or slightly better than the majority of published literature on endocarditis. In the study by Manne et al. [6] , which included 428 patients with both NVE and PVE, the overall early mortality was 10%. The authors noticed that early survival was better in those with NVE compared to PVE, but long-term survival was the same for both groups. They explained that by the fact that early survival may be attributable to the patient's ability to withstand the stress of the early perioperative period and hospitalization. We did not notice the same results early on. We identified several factors that contribute to early mortality. Active endocarditis usually carries a higher mortality due to the urgent/emergent nature of surgery. The presence of multivalve involvement is another factor that adds to the mortality. In the study by Meszaros et al. [7] , the authors reviewed the outcomes of 141 patients with active IE both native and prosthetic. The early mortality was 11%; the 1-and 5-year survival was 84% and 74% for a single-valve endocarditis compared with 46% and 46% for multivalve involvement, respectively [7] . Involvement of the aortic root and the presence of an aortic root abscess is a major sequela of IE, and it was another factor associated with early mortality in our study (P = 0.024). This is related to the extensive nature of the procedure and the major reconstructive process that is usually required with subsequent increase in cardiopulmonary bypass and aortic cross-clamp times. In a large multicentre study of patients with AV endocarditis, 22% had periannular abscess, and it occurred at a higher rate in those with PVE compared with NVE (40% vs 19%) [8] . Kirali et al. [9] reviewed the surgical outcomes of 27 patients presented with aortic root abscess over a 15-year period. Total aortic root replacement was required in 7 (26%) patients. The early mortality was 22% (6 patients), and the overall survival rates at 1, 5 and 10 years were 70%, 63% and 59%, respectively [9] .
Patients who have neurological events in relation to endocarditis represent a major challenge. It has been reported that 15-30% of patients with IE will have cerebral complications [10] . In fact with routine imaging, the expected incidence is much higher [11] . There is great controversy in the literature regarding the proper timing of surgical interventions in those presented with stroke in the settings of IE. In this study, 149 (19%) patients had preoperative stroke; however, perioperative stroke was not a predictor of early or late mortality in our study (P = 0.751). We have divided the time interval between the neurological event and the surgery date into recent (if it was 2 weeks or less) or remote (if it was more than 2 weeks interval). Twenty-nine (19%) patients had their surgery in less than 2 weeks period from the onset of stroke.
In a retrospective review by Okita et al. [12] , the authors discussed the optimal timing of surgery for active IE in patients with cerebral complications. The study included 568 patients who underwent surgery for left-sided active IE in 15 Japanese institutes. Non-haemorrhagic cerebral infarctions were present in 118 patients, and 54 patients had intracranial haemorrhage. Delayed surgery (2 weeks after non-haemorrhagic stroke) was associated with a higher incidence of hospital death compared to those who had surgery within 7 days. On the other hand, patients with intracranial haemorrhage who had surgery within 7 days had higher incidence of hospital death compared to those who had surgery between 8 days and 21 days or after 22 days after the onset of intracranial haemorrhage. The authors concluded that early surgery in active IE in patients with non-haemorrhagic stroke is safe [12] . Delahaye et al. [13] reported the data for a large cohort study and concluded that there is potential harm and no added benefit from delaying surgery in patients with uncontrolled sepsis and risk of embolization. We tend to operate early in IE unless the patient has severe neurological deficit or major intracranial haemorrhage, which matches the current trend in the literature with early surgery [14] .
The choice of prosthesis in the setting of endocarditis has been another subject of controversy for decades. The presence of massive tissue destruction and the need for debridement and the presence of annular abscess have been treated traditionally with homografts and other biological materials. This has been our experience as well. The bulk of the homografts have been used to our advantage in such complex operations as it can fill the large tissue spaces left after aggressive debridement. The other factor that influences our choice of the prosthesis is the associated comorbidities, such as stroke and preoperative embolization, which will definitely influence the choice of the prosthesis in terms of the risks associated with anticoagulation in the immediate postoperative period which forces us sometimes to use biological valves even in younger patients. In this study, we showed that mechanical prostheses carried the best long-term survival compared to bioprostheses or homografts (P = 0.001). In a recent report from our institution about outcomes of surgery in the treatment of isolated non-native MV IE, the type of prosthesis did not affect survival, with the 1-and 5-year survival rates after biological valve implantation were 69% and 38% and 74% and 56% after the mechanical valve implantation, respectively, but the difference was not significant [15] . In a similar manner, Musci et al. [16] reported that comparison of survival rates after the implantation of biological or mechanical prostheses showed no difference in survival between the 2 groups over a period of 10 years. In the study by Moon et al. [17] , the authors reported the outcomes of 306 patients who underwent valve replacement for left-sided NVE or PVE. Mechanical valves were used in 65 patients, while the majority received biological prostheses (221 patients). The operative mortality was independent of replacement valve type; however, long-term survival was superior for those with NVE and survival was independent of prosthesis type. In another study by Delay et al. [18] , the authors reported the immediate and long-term results of 77 patients who underwent valve replacement for NVE and PVE. The overall 5-year survival averaged 61 ± 13% in those who underwent valve replacement with biological valves, which was lower than those who had mechanical valves (71 ± 6%), despite it was not statistically significant (P = 0.7). The reoperation-free survival was also lower with bioprostheses compared with mechanical prostheses but not significant.
Homografts have been considered for a long time as the prostheses of choice in the setting of active IE due to the presumed natural resistance to infection. In our study, the use of homografts was not advantageous. In a recent study by Kim et al. [19] , the authors did not find any significant benefit to the use of homografts especially in relation to the issue of resistance to reinfection. In their study, which included patients from 2 tertiary academic centres, 304 patients were identified. Reinfection occurred in 23 (8%) patients, and there was no significant difference in survival or freedom from reinfection rates based on the type of prosthesis implanted [19] .
Limitations
This study is limited by its retrospective nature. The study population while comprehensive, it included all forms of endocarditis healed or active affecting aortic, mitral and/or tricuspid valves and patients with both NVE and PVE.
CONCLUSION
Surgery for IE still carries a high early mortality and unsatisfactory long-term outcomes. Perioperative neurological events are not a risk factor for early or late mortality and should not be a reason to delay surgery in those with uncontrolled sepsis or more urgent indication for surgery. Mechanical valves are associated with the best long-term survival compared to bioprostheses or homografts. Surgical outcomes in prosthetic endocarditis are no longer different from NVE and early surgery should be considered.
